Found: 11
Select item for more details and to access through your institution.
c-kit (CD117) Expression in Human Tumors and its Prognostic Value: An Immunohistochemical Analysis.
- Published in:
- Pathology & Oncology Research, 2010, v. 16, n. 3, p. 295, doi. 10.1007/s12253-010-9247-9
- By:
- Publication type:
- Article
FOLFIRI and sunitinib as first-line treatment in metastatic colorectal cancer patients with liver metastases -- a CESAR phase II study including pharmacokinetic, biomarker, and imaging data.
- Published in:
- International Journal of Clinical Pharmacology & Therapeutics, 2014, v. 52, n. 8, p. 642, doi. 10.5414/CP202109
- By:
- Publication type:
- Article
First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients with Advanced Solid Tumors.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0083232
- By:
- Publication type:
- Article
IR-TrueFISP: A New DCE-MRI Approach in Comparison with 3D-Flash Multi Flip Angle Method.
- Published in:
- Magnetic Resonance Insights, 2012, n. 5, p. 7, doi. 10.4137/MRI.S9832
- By:
- Publication type:
- Article
A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 6, p. 514, doi. 10.1007/s00280-004-0825-y
- By:
- Publication type:
- Article
Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-510
- By:
- Publication type:
- Article
Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 510, doi. 10.1186/1471-2407-14-510
- By:
- Publication type:
- Article
Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis.
- Published in:
- 2014
- By:
- Publication type:
- journal article